CC
Caxton Corporation Portfolio holdings
AUM
$9.85M
This Quarter Return
+20.42%
1 Year Return
+26.35%
3 Year Return
+409.06%
5 Year Return
+527.59%
10 Year Return
+11,054.45%
AUM
$18.5M
AUM Growth
+$18.5M
(-30%)
Cap. Flow
-$12.9M
Cap. Flow
% of AUM
-69.61%
Top 10 Holdings %
Top 10 Hldgs %
99.27%
Holding
14
New
5
Increased
–
Reduced
4
Closed
2
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$628K |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
$369K |
| 3 |
ABVX
Abivax
ABVX
|
$179K |
| 4 |
Lexeo Therapeutics
LXEO
|
$138K |
| 5 |
HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
|
$129K |
Top Sells
| 1 |
Savara
SVRA
|
$13.9M |
| 2 |
Apogee Therapeutics
APGE
|
$143K |
| 3 |
Aclaris Therapeutics
ACRS
|
$133K |
| 4 |
Compass Therapeutics
CMPX
|
$67.6K |
| 5 |
ALLK
Allakos
ALLK
|
$67.2K |
Sector Composition
| 1 | Healthcare | 94.62% |
| 2 | Financials | 1.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Xeris Biopharma Holdings
XERS
$1.26B
| $13.3M | 71.57% | 5,641,920 | – | – |
|
|
2
Savara
SVRA
$567M
| $1.66M | 8.97% | 353,441 -2,960,161 | -89% | -$13.9M |
|
3
Rezolute
RZLT
$619M
| $1.31M | 7.07% | 1,318,967 | – | – |
|
|
4
SPDR S&P 500 ETF Trust
SPY
$658B
| $628K | 3.39% | +1,322 | New | +$628K |
|
|
MTEM
5
DELISTED
Molecular Templates, Inc.
MTEM
| $511K | 2.76% | 136,866 | – | – |
|
|
6
Berkshire Hathaway Class B
BRK.B
$1.09T
| $369K | 1.99% | +1,035 | New | +$369K |
|
|
7
Apogee Therapeutics
APGE
$2.17B
| $205K | 1.11% | 7,353 -5,119 | -41% | -$143K |
|
|
ABVX
8
Abivax
ABVX
$6.12B
| $179K | 0.97% | +16,743 | New | +$179K |
|
|
9
Lexeo Therapeutics
LXEO
$259M
| $138K | 0.75% | +10,319 | New | +$138K |
|
|
HARP
10
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $129K | 0.7% | +13,176 | New | +$129K |
|
|
11
Compass Therapeutics
CMPX
$483M
| $67.8K | 0.37% | 43,465 -43,308 | -50% | -$67.6K |
|
|
ALLK
12
DELISTED
Allakos
ALLK
| $67.5K | 0.36% | 24,710 -24,619 | -50% | -$67.2K |
|
|
13
Aclaris Therapeutics
ACRS
$209M
| – | – | -19,473 | Closed | -$133K |
|
|
ELEV
14
DELISTED
Elevation Oncology
ELEV
| – | – | -21,813 | Closed | -$14.5K |
|